LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 10 of 483
Next
>>
>
226 to 250 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PD0325901	0.04	uM	LJP5	1	C06	72	hr	1334	3816	3970	0.9610	0.9412
BT-20	PD0325901	0.04	uM	LJP5	2	C06	72	hr	1334	3924	3970	0.9882	0.9822
BT-20	PD0325901	0.04	uM	LJP5	3	C06	72	hr	1334	3922	3970	0.9877	0.9815
BT-20	PD0325901	0.04	uM	LJP6	1	E06	72	hr	1334	3445	3970	0.8676	0.8005
BT-20	PD0325901	0.04	uM	LJP6	2	E06	72	hr	1334	4112	3970	1.0355	1.0535
BT-20	PD0325901	0.04	uM	LJP6	3	E06	72	hr	1334	3845	3970	0.9683	0.9522
BT-20	PD173074	0.04	uM	LJP6	1	I12	72	hr	1334	4425	3970	1.1144	1.1722
BT-20	PD173074	0.04	uM	LJP6	2	I12	72	hr	1334	4147	3970	1.0443	1.0668
BT-20	PD173074	0.04	uM	LJP6	3	I12	72	hr	1334	3849	3970	0.9693	0.9538
BT-20	PD184352	0.04	uM	LJP5	1	L12	72	hr	1334	4031	3970	1.0151	1.0228
BT-20	PD184352	0.04	uM	LJP5	2	L12	72	hr	1334	3910	3970	0.9847	0.9769
BT-20	PD184352	0.04	uM	LJP5	3	L12	72	hr	1334	4372	3970	1.1010	1.1521
BT-20	Pelitinib	0.04	uM	LJP5	1	I18	72	hr	1334	3821	3970	0.9623	0.9431
BT-20	Pelitinib	0.04	uM	LJP5	2	I18	72	hr	1334	4101	3970	1.0328	1.0493
BT-20	Pelitinib	0.04	uM	LJP5	3	I18	72	hr	1334	4066	3970	1.0239	1.0361
BT-20	PF431396	0.04	uM	LJP5	1	E12	72	hr	1334	3846	3970	0.9685	0.9526
BT-20	PF431396	0.04	uM	LJP5	2	E12	72	hr	1334	3796	3970	0.9560	0.9337
BT-20	PF431396	0.04	uM	LJP5	3	E12	72	hr	1334	3594	3970	0.9051	0.8570
BT-20	PF477736	0.04	uM	LJP5	1	J24	72	hr	1334	3463	3970	0.8721	0.8073
BT-20	PF477736	0.04	uM	LJP5	2	J24	72	hr	1334	3281	3970	0.8263	0.7383
BT-20	PF477736	0.04	uM	LJP5	3	J24	72	hr	1334	3809	3970	0.9592	0.9386
BT-20	PF562271	0.04	uM	LJP6	1	F18	72	hr	1334	3655	3970	0.9204	0.8802
BT-20	PF562271	0.04	uM	LJP6	2	F18	72	hr	1334	3705	3970	0.9330	0.8991
BT-20	PF562271	0.04	uM	LJP6	3	F18	72	hr	1334	3815	3970	0.9607	0.9409
BT-20	PHA-665752	0.04	uM	LJP5	1	F18	72	hr	1334	3813	3970	0.9602	0.9401

|<
<<
Previous
Page 10 of 483
Next
>>
>
226 to 250 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)